CVS Health Corporation $CVS Shares Purchased by Aberdeen Group plc

Aberdeen Group plc increased its position in shares of CVS Health Corporation (NYSE:CVS) by 3.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,178,288 shares of the pharmacy operator’s stock after acquiring an additional 34,810 shares during the quarter. Aberdeen Group plc owned approximately 0.09% of CVS Health worth $81,278,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. PDS Planning Inc boosted its position in CVS Health by 10.6% during the second quarter. PDS Planning Inc now owns 4,779 shares of the pharmacy operator’s stock worth $330,000 after acquiring an additional 459 shares during the last quarter. Commerzbank Aktiengesellschaft FI boosted its position in CVS Health by 19.9% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 64,971 shares of the pharmacy operator’s stock worth $4,482,000 after acquiring an additional 10,795 shares during the last quarter. Argyle Capital Management LLC raised its stake in CVS Health by 0.7% during the second quarter. Argyle Capital Management LLC now owns 30,417 shares of the pharmacy operator’s stock worth $2,098,000 after purchasing an additional 200 shares during the period. IFP Advisors Inc raised its stake in CVS Health by 3.7% during the second quarter. IFP Advisors Inc now owns 24,118 shares of the pharmacy operator’s stock worth $1,664,000 after purchasing an additional 862 shares during the period. Finally, Callan Family Office LLC raised its stake in CVS Health by 277.8% during the second quarter. Callan Family Office LLC now owns 121,108 shares of the pharmacy operator’s stock worth $8,354,000 after purchasing an additional 89,053 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CVS shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Saturday, September 27th. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Morgan Stanley increased their price target on shares of CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Bernstein Bank cut their target price on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Finally, Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.80.

CVS Health Stock Performance

CVS Health stock opened at $77.89 on Friday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $79.20. The company has a market capitalization of $98.79 billion, a price-to-earnings ratio of 21.76, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm’s fifty day moving average price is $72.28 and its 200 day moving average price is $67.67.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.